Suchergebnisse - "Patel, Sunil"

PubPharm (11)

1

Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration : A Phase 3 Randomized Clinical Trial

enthalten in: JAMA ophthalmology | 2023

von Woo, S. | Bradvica, M. | Vajas, A. | +16

2

A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration

enthalten in: Ophthalmology | 2023

von Jackson, T. | Slakter, J. | Buyse, M. | +108

3

Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration : The AVENUE Phase 2 Randomized Clinical Trial

enthalten in: JAMA ophthalmology | 2020

von Sahni, J. | Dugel, P. | Patel, S. | +9

4

Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration : The STAIRWAY Phase 2 Randomized Clinical Trial

enthalten in: JAMA ophthalmology | 2020

von Khanani, A. | Patel, S. | Ferrone, P. | +7

CommentIn: JAMA Ophthalmol. 2020 Sep 1;138(9):972-973. - PMID 32729885

5

Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema : BOULEVARD Phase 2 Randomized Trial

enthalten in: Ophthalmology | 2019

von Sahni, J. | Patel, S. | Dugel, P. | +12

6

Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration

enthalten in: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics | 2018

von Callanan, D. | Kunimoto, D. | Maturi, R. | +8

7

A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema

enthalten in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie | 2017

von Callanan, D. | Loewenstein, A. | Patel, S. | +6

8

Enhanced Benefit in Diabetic Macular Edema from AKB-9778 Tie2 Activation Combined with Vascular Endothelial Growth Factor Suppression

enthalten in: Ophthalmology | 2016

von Campochiaro, P. | Khanani, A. | Singer, M. | +9

9

Long-term outcomes of ranibizumab therapy for diabetic macular edema : the 36-month results from two phase III trials: RISE and RIDE

enthalten in: Ophthalmology | 2013

von Brown, D. | Nguyen, Q. | Marcus, D. | +11

10

Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy

enthalten in: JAMA ophthalmology | 2013

von Diabetic Retinopathy Clinical Research Network* | Maturi, R. | Plous, O. | +98